MHLW Warns Of Liver Disorders With Otsuka’s Abilify And Sanofi’s Clexane
This article was originally published in PharmAsia News
Japan’s MHLW orders black box warning for Sanofi’s Clexane; updates labeling for Astellas’ Prograf and Otsuka’s Abilify.
You may also be interested in...
A lower first dose boosted the vaccine’s efficacy result – but AstraZeneca has conceded this has to be proven in a separate trial.
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.